. Iron supplementation improves endurance after training in iron-depleted, nonanemic women. J. Appl. Physiol. 88: 1103-1111, 2000.-Our objective was to investigate the effects of iron depletion on adaptation to aerobic exercise, assessed by time to complete a 15-km cycle ergometer test. Forty-two iron-depleted (serum ferritin Ͻ16 µg/l), nonanemic (Hb Ͼ12 g/dl) women (18-33 yr old) received 100 mg of ferrous sulfate (S) or placebo (P) per day for 6 wk in a randomized, double-blind trial. Subjects trained for 30 min/day, 5 days/wk at 75-85% of maximum heart rate for the final 4 wk of the study. There were no group differences in baseline iron status or in 15-km time. Iron supplementation increased serum ferritin and decreased transferrin receptors in the S compared with the P group. The S and P groups decreased 15-km time and respiratory exchange ratio and increased work rate during the 15-km time trial after training. The decrease in 15-km time was greater in the S than in the P group (P ϭ 0.04) and could be partially attributed to increases in serum ferritin and Hb. These results indicate that iron deficiency without anemia impairs favorable adaptation to aerobic exercise. iron deficiency; endurance capacity; aerobic training; serum transferrin receptors THE PREVALENCE OF IRON DEFICIENCY anemia in US women 18-44 yr of age has been estimated to be 3-5%, whereas the prevalence of iron deficiency without anemia is much higher, ranging from 11 to 13% (18). Furthermore, regular aerobic exercise results in depletion of body iron stores (4, 14, 19) , placing a significant number of young women at risk for iron deficiency as they engage in regular physical activity, which is recommended as part of a healthy lifestyle.
THE PREVALENCE OF IRON DEFICIENCY anemia in US women 18-44 yr of age has been estimated to be 3-5%, whereas the prevalence of iron deficiency without anemia is much higher, ranging from 11 to 13% (18) . Furthermore, regular aerobic exercise results in depletion of body iron stores (4, 14, 19) , placing a significant number of young women at risk for iron deficiency as they engage in regular physical activity, which is recommended as part of a healthy lifestyle.
Decreased work capacity [i.e., maximal O 2 utilization (V O 2 max )] due to iron deficiency anemia in humans has been well documented (5, 6, 11, 29) and is attributed to insufficient O 2 transport by Hb to peripheral tissues. In contrast, the effects of iron depletion without anemia on physical performance have not been well characterized.
With moderate iron deficiency, iron stores are depleted but Hb remains above a specified cutoff point for anemia, and neither O 2 -carrying capacity of the blood nor V O 2 max is compromised (15, 23, 32) . However, animal studies have shown that the activities of ironcontaining muscle mitochondrial oxidative enzymes and respiratory proteins are decreased during iron deficiency without anemia (7, 8, 30) . Because of the role of these iron-dependent enzymes and proteins in oxidative metabolism, it is expected that iron deficiency without anemia would impair the ability to sustain physical performance at 65-85% of maximal capacity, i.e., endurance. Iron-deficient rats with Hb concentrations normalized by transfusion of erythrocytes have compromised endurance capacity in conjunction with decreased oxidative capacity of skeletal muscle (7, 8) . In addition, aerobic training induces increases in irondependent mitochondrial enzyme and respiratory chain cytochrome activities (12, 13) . Thus iron deficiency may also impair the adaptive response to aerobic training.
Studies in experimental animals have demonstrated that iron deficiency severe enough to impair Hb production alters heme and nonheme iron adaptations to training. Tobin et al. (28) showed that iron deficiency, sufficient to reduce Hb ϳ50% compared with control rats, prevented improvements in V O 2 max after 12 wk of endurance training (1.5 h/day, 4 days/wk at 65% V O 2max ). The effects of iron deficiency on nonheme iron responses to training were not reported in this investigation. After a more moderate 4-wk training regimen (1.0 h/day, 6 days/wk at 65% V O 2 max ), Willis et al. (31) found that iron-deficient rats (Hb ϳ50% of controls) improved V O 2 max and endurance but iron-sufficient rats did not. These adaptations in the iron-deficient animals were associated with increased activities of tricarboxylic acid cycle enzymes in skeletal muscle and heart and NADH oxidase in liver, which were absent in iron-sufficient animals. After a similar training protocol, Willis et al. (30) also reported increased cytochrome c, tricarboxylic acid cycle enzymes, and manganese superoxide dismutase activities in skeletal muscle of iron-deficient, but not iron-sufficient, animals (30) . These studies demonstrate that heme and nonheme iron responses to training are altered by iron deficiency.
The effects of iron depletion without anemia on adaptation to training in young women have not been fully characterized. Iron supplementation of irondeficient, but not anemic (Hb Ͼ120 g/l), women who were physically active (16) or who underwent a prescribed training program (20) significantly increased Hb, serum ferritin (sFer), and V O 2 max compared with placebo. In both studies, change in V O 2 max was significantly and positively associated with change in Hb in the iron-supplemented women. Newhouse et al. (23) found that iron supplementation increased sFer in
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iron-depleted, nonanemic female runners but did not alter Hb or V O 2 max . These studies are consistent with the idea that O 2 delivery to the peripheral tissues is the primary determinant of V O 2max (26) . Because Hb concentration was increased in the iron-treated women in these studies, the authors were unable to assess the effects of iron deficiency independent of O 2 -carrying capacity on performance. Rowland et al. (25) found that iron supplementation of iron-depleted runners who continued their normal training regimen resulted in significant improvements in treadmill running times and sFer concentrations but did not alter Hb or V O 2 max . However, there was a significant, positive association between changes in treadmill running time and changes in sFer. Klingshirn et al. (15) , in a similar supplementation trial of iron-deficient women runners, demonstrated significant increases in sFer but no effect on Hb, V O 2 max , or endurance after supplementation compared with placebo.
The results of the animal and human studies, taken together, suggest that iron deficiency impairs the adaptive response to training at maximal levels by preventing attainment of optimal Hb and at submaximal levels by impairing oxidative capacity of peripheral tissues. However, the effects of iron deficiency without anemia on the response to endurance training and on submaximal work capacity in previously untrained women have yet to be elucidated.
Previous work from this laboratory has demonstrated that iron depletion without anemia reduces the endurance capacity of untrained women by increasing energy expenditure and fractional O 2 utilization (%V O 2 max ) after controlling for work rate (34) . The goal of this follow-up study was to determine whether iron depletion impairs the ability of nonanemic, previously untrained women to increase endurance capacity in response to 4 wk of aerobic training on a cycle ergometer. The specific objectives of this investigation were 1) to study the effects of iron supplementation on endurance capacity as assessed by performance during a 15-km time trial on a cycle ergometer, 2) to test the effects of iron supplementation on metabolic adaptations to training during the time trial, including ventilation, gas exchange, and plasma lactate concentrations, and 3) to investigate the relation of iron status indicators to endurance capacity and energy metabolism during the time trial after 4 wk of physical training.
METHODS

Subjects.
Two hundred seventy-one physically active, untrained 19-to 35-yr-old women were recruited from the local community. Forty-nine women were identified as irondepleted without anemia on the basis of Hb concentrations Ͼ120 g/l and sFer concentrations Ͻ16 µg/l in preliminary screenings. After physical examination, including a medical history, no subjects were found to possess the following exclusion criteria: current pregnancy or pregnancy within the previous year, recent infectious illness or fever, hemolytic anemia, asthma, musculoskeletal problems, recent history of eating disorders, smoking, excess alcohol consumption, recent use of recreational drugs, consumption of prescription medications that may interfere with dietary iron absorption, or participation in competitive athletics.
Data from four women were excluded from data analysis because of high baseline ferritin concentrations, indicating that their screening ferritins misclassified them as iron depleted, and three women dropped out for personal reasons unrelated to the study. Thus 42 women qualified and were willing to participate in the study. Signed informed consent was obtained from each subject. This study was approved by the Cornell University Committee on Human Subjects.
Study design. The experimental design of the study was a randomized, double-blind, placebo-controlled intervention trial. Subjects were randomly assigned to two groups, receiving an iron supplement or a placebo; all subjects completed 4 wk of aerobic training. Subjects took an iron supplement of 50 mg of ferrous sulfate (10 mg of elemental iron) or an identical placebo capsule two times a day for 6 wk. Previous work in our laboratory demonstrated that iron status is improved after 4 wk of iron supplementation by use of a similar dose of ferrous sulfate (33) . The capsules were prepared in our laboratory with the use of gelatin capsules (Apothecary Products, Minneapolis, MN), ferrous sulfate, and lactose filler. The iron content of the capsules was determined from a random sample of 20 capsules [49.4 Ϯ 4.2 (SD) mg of ferrous sulfate]. The subjects were instructed to consume the capsules with citrus juice to enhance iron absorption and with meals to reduce side effects. They were also instructed to avoid consumption of any other multivitamin and mineral supplements during the entire study period. Subjects recorded capsule ingestion, consumption of medication, illness, menstrual status, gastrointestinal symptoms, physical activity, and musculoskeletal problems in a daily log. Unsolicited verbal reports from the subjects indicated that they were unable to detect whether they received iron or placebo.
After 2 wk of iron or placebo treatment, exercise training was initiated. The 4-wk training regimen (5 sessions/wk) was performed on a cycle ergometer (Cateye ergociser E-3200) equipped with a heart rate (HR) monitor and digital output of cadence and work (in W). The training sessions included a 4-min warm-up followed by a 25-min cycling session divided between workloads that allowed subjects to achieve a target HR of 75% of maximum HR (HR max ) and 85% HR max . Over the course of the 4-wk training program, the time spent at 75% HR max was decreased from 20 to 10 min, with a corresponding increase in the duration of cycling at 85% HR max (i.e., 20 min at 75% HR max and 5 min at 85% HR max in week 1 and 10 min at 75% HR max and 15 min at 85% HR max in week 4). Previous studies have demonstrated that aerobic exercise of similar intensity and duration is sufficient to produce measurable improvements in endurance capacity (3) . Subjects recorded HR, average cadence, and work (in W) for each training session in a training log.
Prestudy habitual physical activity levels were assessed by a frequency questionnaire, which was analyzed using the method described previously (32) to obtain a physical activity score for each subject. This was done to confirm similar habitual physical activity between groups after randomization. To ensure that the prescribed training regimen was the only additional source of physical activity, subjects were asked to maintain their prestudy activity level during the entire study period. To maximize the potential to respond to physical training, highly trained women and competitive athletes were excluded from the study.
For all subjects, body composition and physical performance were measured immediately before and after the 6-wk treatment period. In addition, baseline dietary iron intake was assessed by a dietary record over 4 consecutive days, including 1 weekend day. The dietary records were analyzed using Nutritionist IV (Hearst, San Bruno, CA) to quantify dietary iron intake.
Physiological measurements. Exercise tests (V O 2 max and 15-km time trial) were conducted on a mechanically braked and calibrated cycle ergometer (model 818E, Monark, Varberg, Sweden) with a computerized metabolic cart (Physiodyne, Quogue, NY) in the Human Bioenergetics Laboratory at Cornell University. The ergometer was equipped with a digital readout of cadence (in rpm) or distance (in km) pedaled. Concentrations of O 2 and CO 2 in expired air and respiratory volume were analyzed with gas analyzers (Ametek, Pittsburgh, PA) and a respiratory pneumotachograph (Fitco Micro Flow, Fitness Instrument Technologies, Farmingdale, NY) through a breathing valve (Hans Rudolph, Kansas City, MO). Data output from the instruments was directed to an IBM 386 computer for the breath-by-breath calculation of O 2 consumption (V O 2 ), CO 2 production (V CO 2 ), respiratory exchange ratio (RER, V CO 2 /V O 2 ), and minute ventilation. HR was monitored throughout the tests with an electrocardiograph (Burdick, Milton, WI).
Subjects were asked not to perform any strenuous physical activities 2 days before the exercise tests. To control for the effects of dietary intake before exercise testing, subjects were instructed to start recording food intake 3 days before the pretreatment exercise testing and to continue until the last day of pretreatment testing; they were further instructed to repeat the same dietary intake for the posttreatment exercise tests. In addition, the posttreatment exercise tests were repeated at approximately the same time of day as the pretreatment tests to minimize the effects of acute differences in dietary intake and time of day. Subjects were instructed not to consume food or caffeinated or carbonated beverages within the 3 h preceding the exercise tests.
To standardize the relative intensity of the workload for each subject during the 15-km time trial at 70% V O 2 max , maximal aerobic capacity was determined. The protocol was a modification of that described by McArdle and Magel (22) for the cycle ergometer. Testing began with a 5-min warm-up at 30 W and a pedaling cadence of 60 rpm. The workload was increased by 30-W intervals every 2 min until V O 2 stopped increasing or the subject could not continue. V O 2 max was achieved if two of three of the following criteria were met: V O 2 increased by Ͻ150 ml with an increase in workload, RER was Ͼ1.10, or HR max was within Ϯ10 beats of age-predicted maximum (220 Ϫ age in yr). Test-retest reliability for the V O 2 max test for similar subjects in our laboratory is r ϭ 0.91.
Endurance capacity was tested by a 15-km time trial administered 2 days after the V O 2 max test. Performance was measured as time to complete the 15-km time trial. Subjects were asked to finish the time trial as quickly as possible, against a predetermined resistance. The level of the resistance allowing the subject to achieve 70% of V O 2 max while pedaling at 60 rpm was determined for each individual on the basis of her pretreatment V O 2 max test. The same resistance level was used at the posttreatment endurance test. Standardized words of encouragement were used by the investigator throughout the test. During the test, V O 2 , V CO 2 , and HR were continuously monitored. Cadence was recorded each minute and was used to calculate absolute work rate. Test-retest reliability of this protocol determined in our laboratory is r ϭ 0.93 for average V O 2 during the time trial and r ϭ 0.99 for average work rate during the time trial.
Blood samples were obtained by finger punctures immediately before the time trial, after 5, 10, and 15 km, and 10 min after completion of the time trial. Blood samples were drawn into 100-µl heparinized capillary tubes, sealed, stored on ice, centrifuged immediately after the test, and stored at Ϫ20°C for determination of lactate concentration. Lactate concentration in plasma was determined enzymatically (Sigma Diagnostics, St. Louis, MO). Pre-and posttreatment samples for each subject were analyzed concurrently at the completion of the study to eliminate variation in assay conditions. Body size and composition were measured in the Human Body Composition Laboratory at Cornell University. Anthropometry (weight and height) was assessed using standard procedures described in Lohman et al. (17) . Body fat (i.e., fat mass) and fat-free mass were assessed by densitometry following the technique described by Aker and Buskirk (1). The Siri equation adapted for women was used, with the assumption that the density of fat-free mass is 1.096 g/ml.
Iron status measurements. Iron status was assessed at screening and before, at the midpoint (3 wk), and after iron treatment (6 wk). Blood samples were obtained from the seated subject in the fasted state from the antecubital vein into two evacuated tubes: one contained EDTA, and the other was empty. Hb and hematocrit were assayed in whole blood immediately after sample collection. Coagulated blood was separated immediately by centrifugation at 1,640 g for 10 min at room temperature. Aliquots of serum samples were frozen at Ϫ20°C. To control for potential variation in assay conditions, serum samples [serum transferrin receptor (sTfR), sFer, and iron (sFe) and total iron-binding capacity (TIBC)] for the same subject at all three time points were analyzed concurrently at the completion of the study.
Hb was determined by the cyanomethemoglobin method described by van Assendelft and England (2) (Sigma Diagnostics). Hematocrit was determined by the microhematocrit method. sTfR and sFer were assessed by ELISA according to the methods of Flowers et al. (9, 10) (Ramco Laboratories, Houston, TX). Transferrin saturation (TS) was determined from the ratio of sFe to TIBC by the method described by Persijin et al. (24) (Sigma Diagnostics). To control for day-today variation and to increase measurement precision, the averages of two independent measures of Hb and sFer concentrations, at screening and before iron treatment, which were 3-7 days apart, were used as the pretreatment concentrations.
Statistical analysis. Data were examined to verify normality of distribution. The physical activity data showed a skewed distribution, and statistical analysis was performed on logarithmically transformed data. Independent Student's t-test was used to test group differences at baseline. Repeatedmeasures ANOVA was used to test group and time effects as well as group-by-time interactions for measures of iron status. Regression analysis with baseline measurements as covariates was used to analyze group differences in posttreatment iron status or physical performance. The effects of final iron status on final outcome variables were analyzed by multiple linear regression analysis (GLM), controlling for baseline outcome values and iron status as well as other potential confounding or mediating factors. Statistical significance was indicated at P Ͻ 0.05. Values are means Ϯ SE. To test whether initial iron status modifies the effects of supplementation on outcome variables, appropriate interaction terms were included in the multiple linear regression model. An interaction was considered statistically significant at P Ͻ 0.2. All statistical analyses were performed using SAS version 6.0 (27) on a personal computer.
RESULTS
Subject characteristics.
The placebo and supplemented groups were of similar age (20.
0.01 m, respectively). Body weight and composition did not differ between the two groups before or after the study, nor were there significant changes during the study (Table 1) . Habitual physical activity did not differ between groups, nor were there significant group differences in the number of training sessions or total work performed during the training (data not shown). There were no group differences in dietary iron intake on the basis of the 4-day diet records (14.8 Ϯ 1.9 and 14.7 Ϯ 1.1 mg iron/day for placebo and supplemented groups, respectively). Likewise, there were no group differences in reported symptomology associated with iron treatment.
Response to iron treatment. Results of analysis of blood indexes of iron status measured at 0, 3, and 6 wk of the study are shown in Table 2 . There were no significant group differences in any measure of iron status at baseline. After 3 wk of treatment, the ironsupplemented group exhibited significant increases in sFer, sFe, and TS above baseline values that persisted after 6 wk of treatment. In the supplemented group the sTfR concentration decreased over the course of the study and was significantly less than baseline after 6 wk of iron treatment. Response of sTfR to the iron supplement was dependent on initial sTfR, such that women who began the study with higher sTfR (i.e., lower tissue iron) exhibited a greater decrease in sTfR by the end of the study (supplementation by initial sTfR interaction P ϭ 0.019). In the placebo group, there were no significant changes in any indicator of iron status throughout the course of the study. sFer, sFe, and TS were significantly greater and sTfR was significantly lower in the iron-supplemented group than in the placebo group after 6 wk of treatment. There was a significant negative correlation between sTfR and sFer at baseline (r ϭ Ϫ0.56) and 6 wk (r ϭ Ϫ0.70), whereas Hb was positively correlated with Hct (r ϭ 0.74 and 0.88) and TS (r ϭ 0.64 and 0.62) at both time points.
Time trial. Results of the physical performance measurements taken during the 15-km time trial before and after iron treatment and exercise training are presented in Table 3 . There were no significant differences between the supplemented and placebo groups at baseline, although V O 2 max tended to be lower (Table 3) , %V O 2 max tended to be higher, and more time was taken to complete the test (P Ͻ 0.1) in the supplemented group compared with placebo. Posttest V O 2 max , RER, work rate, and time to complete the time trial were Values are means Ϯ SE for 20 placebo (P) and 22 iron-supplemented (S) subjects. significantly improved in both groups, suggesting a positive effect of the 4-wk training regimen.
Time to finish the time trial. There was a significant effect of iron supplementation on time to complete the 15-km time trial. The supplemented group showed an improvement in finishing time twice that of the placebo group (Ϫ1.6 Ϯ 0.5 and Ϫ3.4 Ϯ 0.6 min for placebo and supplemented groups, respectively), controlling for baseline time to complete the time trial. The improved finishing time by the supplemented group was primarily due to faster times in the second (P ϭ 0.082) and third (P ϭ 0.027) 5-km segments of the time trial (Fig. 1) .
To assess further the effect of iron status on time to complete the time trial, multiple linear regression analysis was used with time to finish as the dependent variable and indicators of iron status as independent variables, controlling for potential confounders such as %V O 2 max , absolute work rate, and training level. Only absolute work rate was correlated with 15-km time, and it was included as a covariate in all regression models. Model 1 in Table 4 shows that supplementation decreased time to finish by 1.61 Ϯ 0.76 min (P ϭ 0.04), controlling for baseline time to finish and posttest work rate during the time trial. After addition of either initial and final sFer (Table 4 , model 2) or Hb (Table 4 , model 4) to the model, the significance of supplementation as a predictor of completion time was reduced, indicating that the effect of supplementation was partially due to changes in iron status. Final sTfR accounted for a greater proportion of the supplementation effect compared with Hb (Table 4 , models 2 and 4). Adding sTfR to the model decreased the group coefficient ϳ70% (␤ group decreased from Ϫ1.612 to Ϫ0.437), whereas including Hb in the model decreased the group coefficient only 20% (␤ group decreased from Ϫ1.612 to Ϫ1.267).
Energy expenditure and absolute work rate. The rate of energy expenditure during the time trial was calculated for each subject on the basis of her average V O 2 and average nonprotein RER during the time trial (Table 5) after McArdle et al. (21) . The total energy expended during the time trial was similar in the preand posttests for both treatment groups. The supplemented group was less efficient than the placebo group at baseline on the basis of energy expenditure (in kcal) per unit of work performed (in W). The iron-supplemented group significantly increased the rate of energy expenditure 0.57 Ϯ 0.23 kcal/min above baseline, whereas the placebo group was unchanged. There were no significant group differences in total energy expenditure or in the rate of energy expenditure, controlling for baseline energy expenditure and absolute work rate or %V O 2 max . The results of multiple linear regression analysis to examine relationships between energy expenditure, work rate, efficiency, and iron status are Values are regression coefficients (␤), with corresponding P values. TT WR, average work rate during TT after iron treatment; Group, treatment group (0 for placebo group, 1 for iron-supplemented group); root MSE, root mean square error. Values are means Ϯ SE for 20 placebo and 22 iron-supplemented subjects. * Significantly different from pretreatment, P Ͻ 0.05. † Significantly different from P group at baseline, P Ͻ 0.05.
shown in Table 6 . Total energy expended during the 15-km time trial was significantly and negatively associated with the change in Hb concentration from 0 to 6 wk, after controlling for pretreatment energy expenditure. For every 1 g/l increase in Hb there was a 1.04-kcal decrease in energy expended. Similarly, there was a significant positive relationship between changes in Hb and absolute work rate during the time trial, after controlling for initial work rate. As a result, changes in Hb were positively associated (P ϭ 0.09) with changes in efficiency (i.e., the energy expended per watt of work performed).
%V O 2 max and RER. The iron-supplemented group significantly decreased %V O 2max , increased average V O 2 , and tended to increase total O 2 consumed during the time trial (ϩ4.2 Ϯ 2.3 liters of O 2 , P ϭ 0.08) compared with baseline, whereas in the placebo group, these parameters remained unchanged (Table 3) . At 6 wk, both groups significantly decreased average RER for the test and increased the absolute work rate. There were no significant group differences in final %V O 2 max or final RER. Multiple linear regression was used to further explore the relationships between iron status and posttreatment %V O 2 max and RER, controlling for pretreatment performance and potential confounders, i.e., work rate and training. For %V O 2 max , there was a significant positive relationship with final sTfR (␤ ϭ 1.14, P ϭ 0.005) after controlling for training, pretreatment %V O 2 max , and initial sTfR (equation not shown), indicating that for each 1 µg/l decrease in sTfR, there was a 1.14% decrease in %V O 2 max during the final time trial.
Physical performance during the final 5 km. Because the effect of supplementation was greatest in the time to complete the final 5-km segment of the time trial (Fig. 1) , the metabolic responses during this portion of the test were analyzed separately (Table 7) . This was done to test for group differences that may not have been evident when the entire 15-km test was analyzed as a whole. However, the results for the final 5 km were similar to those for the entire test. Both groups significantly decreased RER and energetic efficiency during the last 5 km in the posttest compared with baseline. The iron-supplemented group significantly increased average V O 2 , decreased %V O 2 max , and increased the rate of energy expenditure (i.e., kcal/min) in the posttest compared with baseline.
Initial iron status and adaptation to training. Initial iron status modified the effect of iron supplementation on adaptation to training. That is, there were significant interactive effects between supplementation and initial sTfR concentrations on changes in physical performance. The effect of supplementation to decrease 15-km time (supplementation by initial sTfR interaction P ϭ 0.18) and %V O 2 max (supplementation by initial sTfR interaction P ϭ 0.03) and to increase absolute work rate (supplementation by initial sTfR interaction P ϭ 0.17) was greater in women with lower initial tissue iron stores. This result is similar to the interactive effect between initial sTfR and supplementation on final sTfR described above.
Lactate. Changes in serum lactate over the course of the 15-km time trial are shown in Table 8 . As expected, lactate levels increased ϳ2.5-fold above the pretest value after the first 5 km of the time trial and remained elevated for the duration of the test. Serum lactate was significantly reduced in the posttreatment time trial at four of the five time points in both groups (i.e., week 0 vs. week 6). There were no differences between the treatment groups in pretreatment lactate levels (i.e., at week 0), nor were there significant differences during the posttreatment trial after controlling for pretreatment and pretest lactate and work rate during the final time trial test. Values are means Ϯ SE for 20 placebo and 22 iron-supplemented subjects. * Significantly different from pretreatment, P Ͻ 0.05. † Significantly different from P group at baseline, P Ͻ 0.05.
DISCUSSION
Improvements in endurance demonstrate that the training regimen employed in this study was adequate to induce physiological adaptation. Likewise, the supplementation regimen effectively improved iron status. After 3 wk of iron supplementation, sFer, sFe, and TS increased significantly from baseline in the irontreated group and were significantly greater than in the placebo group. sTfR improved significantly after 6 wk of supplementation and was significantly reduced compared with placebo.
Iron supplementation enhanced the favorable adaptive response to training, as evidenced by a greater improvement in time to finish the 15-km time trial than with the placebo (Table 3 ). The greater improvement in the supplemented group was due to faster times in the second and third 5-km segments of the test, suggesting that these women were better able to sustain the workload at the end of the time trial and thus had increased their endurance capacity (Fig. 1) . Furthermore, the plausibility that the supplementation effect on time to complete the time trial was due to changes in iron status was substantiated by linear regression analysis. This analysis demonstrated that the supplementation effect could be partially attributed to improvements in sFer and, to a lesser extent, in Hb (Table  4) . This is consistent with the significant, positive association between change in endurance time and sFer in runners who maintained their usual training reported by Rowland et al. (25) .
Although time to finish the 15-km time trial was significantly improved with iron supplementation, there were no significant differences in other measures of physical performance assessed during the time trial test. The training regimen employed in this study produced significant improvements in fitness that may have overridden any additional benefits of iron supplementation. For example, LaManca and Haymes (16) found a 3% decrease in %V O 2 max during a time-toexhaustion endurance test after 8 wk of iron supplementation in women with mild anemia; in the present study, %V O 2 max was decreased ϳ5% in the placebo group after 4 wk of training. Furthermore, studies in rats have shown that iron deficiency does not obviate the ability to respond to endurance exercise via non-irondependent mechanisms (e.g., cardiovascular improvements) (31) .
Multiple linear regression analysis showed that changes in iron status were related to changes in physical performance independent of the supplementation effect. Decreases in sTfR were positively associated with improvements in %V O 2 max , suggesting increased efficiency of O 2 utilization at the tissue level with improved tissue iron status. This finding is consistent with tissue iron, i.e., muscle oxidative capacity, being a limiting factor in endurance capacity (8, 30, 31) .
The women in this study were not anemic on the basis of a cutoff of Hb Ͼ120 g/l. However, multiple regression analysis demonstrated that energetic efficiency was improved with increases in Hb. Improvements in Hb resulted in decreased energy expenditure, increased work rate, and increased efficiency during the time trial (Table 6 ). Zhu and Haas (34) found a similar functional anemia in untrained women with Hb Ͼ120 g/l, evidenced by negative associations between Hb and time, %V O 2 max , and lactate during the same 15-km time trial protocol used in this study. That is, women with Hb Ͼ120 g/l may still be functionally anemic, having an Hb concentration that is not sufficient for optimal physical performance in stressful situations such as a 15-km time trial. The potential for functional anemia is greater in the present study because of the 4-wk aerobic training regimen, which may further increase the demand for greater O 2 -carrying capacity (i.e., Hb) and tissue iron. Studies by Magazanik et al. (20) and LaManca and Haymes (16) demonstrating increases in Hb with iron supplementation and significant, positive associations between changes in Hb and V O 2 max in physically active women who were not anemic (i.e., Hb Ͼ120 g/l) also support a functional anemia associated with training.
Investigations of the effect of iron supplementation on blood lactate response during sustained submaximal exercise are equivocal and depend on the severity of the iron deficiency, level of exertion during the test, and fitness level of the subjects. LaManca and Haymes (16) reported a significant decrease in lactate in ironsupplemented women after an endurance test compared with placebo, whereas Klingshirn et al. (15) found no significant supplement effect on posttest lactate. The discrepancy may be attributed to differences in initial iron status between the two studies. The athletes in the study by LaManca and Haymes had lower initial Hb, which significantly improved with supplementation, whereas Hb was unchanged by supplementation in the study by Klingshirn et al. In the present study, no effect of iron supplementation on blood lactate was found during or after the time trial, nor was Hb changed due to supplementation. Another possible explanation for the lack of supplementation effect on lactate during the time trial is the large training effect (lactate decreased ϳ20% in the placebo group; Table 8 ) which may have obscured any additional supplementation effect.
In conclusion, we have demonstrated that iron supplementation enhances favorable physiological adaptation to endurance training and thus increases endurance capacity in iron-depleted, nonanemic women. Furthermore, associations between improved Hb, sFer, and sTfR status and physical performance during prolonged, submaximal exercise suggest that tissue iron stores and, to a lesser extent, O 2 -carrying capacity mediate the adaptation to aerobic training. These results are relevant for exercising young women whose dietary patterns and physical activity levels increase their risk of iron deficiency and suggest that repletion of iron stores may maximize the benefits of aerobic training.
